SOUTH SAN FRANCISCO, Calif., Feb. 1, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the executive management team will participate in the 12th Annual BIO CEO & Investor Conference to be held February 8 through February 9, 2010 in New York City at the Waldorf-Astoria.
